Previous Close | 0.2530 |
Open | 0.2540 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.2490 - 0.2735 |
52 Week Range | 0.1440 - 0.9420 |
Volume | |
Avg. Volume | 25,224 |
Market Cap | 41.647M |
Beta (5Y Monthly) | 1.89 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.1020 |
Earnings Date | Feb 27, 2023 - Mar 03, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
VANCOUVER, BC, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Fobi AI Inc. (FOBI:TSXV) (FOBIF:OTCQB) (the "Company" or "Fobi"), an industry leader in harnessing AI and data intelligence to enable digital transformation, is pleased to announce that the company’s wholly-owned subsidiary, PulseIR, has signed a new deal with integrated healthcare provider, Empower Clinics. Empower offers a telemedicine platform for healthcare and diagnostics solutions across the U.S. and Canada. PulseIR is a platform as a servic
VANCOUVER, BC, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Fobi AI Inc. (FOBI:TSXV) (FOBIF:OTCQB) (the "Company" or "Fobi"), an industry leader in harnessing AI and data intelligence to enable digital transformation, is pleased to announce the commercial launch of its wholly-owned subsidiary, PulseIR, with the signing of its first customer, PanGenomic Health Inc. PanGenomic offers a self-care digital platform to deliver personalized, evidence-based information about natural and plant-based health treatmen
Deal with Wunderman Thompson Netherlands offers brands a new way to enhance customer engagement.VANCOUVER, B.C., Jan. 26, 2023 (GLOBE NEWSWIRE) -- Fobi AI Inc. (FOBI: TSXV FOBIF: OTCQB) (the “Company” or “FOBI”), an industry leader in harnessing AI and data intelligence to enable digital transformation, is pleased to announce a new partnership between Wunderman Thompson Commerce & Technology Netherlands and Passcreator by Fobi that will enable brands to enhance customer communications and boost